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Systematic review of the effectiveness of stage based
interventions to promote smoking cessation
Robert Paul Riemsma, Jill Pattenden, Christopher Bridle, Amanda J Sowden, Lisa Mather,
Ian S Watt, Anne Walker
Abstract
Objective To evaluate the effectiveness of
interventions using a stage based approach in
bringing about positive changes in smoking
behaviour.
Design Systematic review.
Data sources 35 electronic databases, catalogues, and
internet resources (from inception to July 2002).
Bibliographies of retrieved references were scanned
for other relevant publications, and authors were
contacted if necessary.
Results 23 randomised controlled trials were
reviewed; two reported details of an economic
evaluation. Eight trials reported effects in favour of
stage based interventions, three trials showed mixed
results, and 12 trials found no statistically significant
differences between a stage based intervention and a
non-stage based intervention or no intervention.
Eleven trials compared a stage based intervention
with a non-stage based intervention, and one reported
statistically significant effects in favour of the stage
based intervention. Two studies reported mixed
effects, and eight trials reported no statistically
significant differences between groups. The
methodological quality of the trials was mixed, and
few reported any validation of the instrument used to
assess participants’ stage of change. Overall, the
evidence suggests that stage based interventions are
no more effective than non-stage based interventions
or no intervention in changing smoking behaviour.
Conclusions Limited evidence exists for the
effectiveness of stage based interventions in changing
smoking behaviour.
Introduction
The health hazards of smoking are important and well
established. Diseases that are more common in smok-
ers than in the general population include lung cancer,
other lung disease, and cardiovascular disease.1 Smok-
ing is the greatest single cause of illness and premature
death in the United Kingdom, with more than 120 000
deaths in 1995 of people aged over 35 years
attributable to smoking.2 3
In the United Kingdom in 1997, more than 11 mil-
lion adults—about 27% of the adult population—were
regular smokers. The proportions of men and women
who currently smoke are about the same.Over the past
five years the proportion of smokers in the population
has stabilised or may even be increasing, as about 25%
of 15 year olds are regular smokers.3 4
The risk of disease is reduced after smoking cessa-
tion. People who stop smoking before middle age can
avoid most of the excess risk they would have carried.1
After only one year of abstinence the excess risk of
death related to myocardial infarction and cerebral
arterial disease is decreased by one half as is the risk of
dying from smoking related disease in those who stop
before the age of 50.5 Depending on the number of
years of abstinence, the risk of developing lung cancer
can be reduced by 20% to 90%.6 Treatment for
smoking related disease costs the NHS around
£1500m ($2414m; €2095m) annually.3
Several methods are currently used for smoking
cessation, including pharmacological methods such as
nicotine replacement therapy or antidepressants
(bupropion), hypnotherapy, and exercise based inter-
ventions. Behavioural approaches include stage based
interventions, which largely use the transtheoretical
model.7 This model separates individuals into five
different stages: precontemplation, contemplation,
preparation, action, and maintenance. Progression
through the stages is sequential, although relapse to an
earlier stage can occur. The model also recognises 10
processes of change, the theory being that the
effectiveness of the different processes of change will
vary according to the patient’s stage, although this has
not always been supported in empirical studies.8–10
Interventions derived from stage theories of behav-
iour change usually incorporate several key elements.
It is necessary to identify accurately an individual’s
stage of change (or readiness to change), so that an
intervention based on stage specific processes of
change can be applied. Stage of change needs to be
reassessed frequently, and the intervention should
reflect changes in the individual’s readiness to change.
These elements of the intervention are repeated until
the individual achieves and maintains the change in
behaviour. In this way, stage based interventions evolve
and adapt in response to the individual’s movement
through the stages of change.7 11
Stage based models propose that interventions that
take into account the current stage of the individual
will be more effective and efficient than “one size fits
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all” interventions. Services aimed at smoking cessation
have made extensive use of the approach. A recent sur-
vey on training in smoking cessation in England found
that the stages of change model and motivational
interviewing were the main topics covered in training
courses, as well as the primary theory used to explain
behaviour change.12 Between April 2001 and March
2002 the UK government’s expenditure on smoking
cessation services in England was £24.7m.13 This does
not include nicotine replacement therapy or bupro-
pion but does include training in smoking cessation for
staff in primary and secondary care.13 14
Despite the widespread use of stage based models,
evidence on the effectiveness of this approach may be
limited.15–18 We assessed the available evidence.
Methods
We searched 35 electronic databases from inception to
July 2002 and the internet using several search
engines. The bibliographies of retrieved references
were scanned for further relevant publications. The
authors of abstracts in conference proceedings were
contacted for further information.
Eligible for inclusion were randomised controlled
trials evaluating the effectiveness of stage based
interventions in influencing smoking behaviour—such
as actual behaviour change or movement through dif-
ferent stages. No restrictions were applied to partici-
pants other than they had to be smokers, and there
were no restrictions on language or publication date.
Two reviewers independently assessed the titles and
abstracts and then assessed relevant papers against the
predetermined selection criteria. Data were extracted
by one reviewer into structured summary tables and
checked by a second reviewer. Extracted data included
smoking behaviour, movement through stages, adverse
effects, and cost effectiveness.
Each included trial was assessed for methodological
quality and the quality of the implementation of the
Table 1 Methodological quality of included studies with stage based interventions aimed at smoking cessation
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Berman et al
1995w1
4/13 Yes Not stated Not stated Not stated No Not stated Not stated No Yes
Butler et al
1999w2
9/13 Yes Yes Not stated Yes No Yes Not applicable No Yes
Cornuz et al
2002w3
12/13 Yes Yes Yes Yes Yes Yes Not applicable No Yes
DiClemente et al
1991w4
5/13 Yes Not stated Not stated Not stated No No No Yes Yes
Dijkstra et al
1999w5
6/11 Not stated Not stated Not applicable Not stated Not applicable No Yes Yes Yes
Emmons et al
2001w6
9/13 Yes Yes No Not stated No Yes Not applicable Yes Yes
Etter and
Perneger
2001w7
9/13 Yes Not stated No Not stated Not applicable Yes Not applicable Yes Yes
Gritz et al
1993w8
3/13 Not stated Not stated Not stated Not stated No Not stated No No Yes
Lennox et al
1998w9
8/13 Not stated Yes Yes Not stated No No Yes No Yes
Lennox et al
2001w10
7/13 Yes Not stated Not stated Not stated Not stated No Yes No Yes
Morgan et al
1996w11
5/13 Not stated Not stated Not stated Not stated No No No Yes Yes
Pallonen et al
1994w12
2/12 Not stated Not stated Not applicable Not stated No Not stated Not stated No Yes
Pallonen et al
1998w13
6/12 Yes Not stated Not stated Not stated Not applicable Yes Not applicable No Yes
Pieterse et al
2001w14
8/13 Yes No Yes Not stated Not stated No Yes No Yes
Pletsch 2002w15 6/13 No Not stated Not stated Not stated Not stated Yes Not applicable Yes Yes
Prochaska et al
2001w16
5/13 Not stated Not stated Not stated Not stated Not applicable Yes Not applicable No Yes
Prochaska et al
2001w17
5/13 Not stated Not stated Not stated Not stated Not stated Yes Not applicable No Yes
Reeve et al
2000w18
3/13 Not stated Not stated Not stated Not stated Not stated Not stated No No Yes
Resnicow et al
1997w19
7/13 Not stated Not stated Not stated Not stated No No Yes Yes Yes
Sinclair et al
1999w20
3/13 Not stated Not stated Not stated Not stated No Not stated Not stated Yes Yes
Stotts et al
2002w21
6/13 Yes Yes Not stated Not stated Not stated No Yes No Yes
Tappin et al
2000w22 w24
8/13 Yes Yes Not stated Not stated Not stated Yes Not applicable Yes Yes
Wang 1994w23 6/13 Not stated Not stated Not stated Not stated No Yes Not applicable Yes Yes
Continued on next page
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intervention.19 Quality assessment was performed by
one reviewer and checked by a second reviewer.
Disagreements were resolved by discussion. We were
unable to carry out pooling because the studies were too
heterogeneous for interventions, participants, settings,
and outcomes; therefore we present a qualitative
synthesis.
Results
We identified 23 randomised controlled trials meeting
our inclusion criteriaw1-w23; two included an economic
evaluation.w2 w20
Quality assessment
The methodological quality of the trials varied (table 1).
We assessed 13 criteria for quality; the number present
ranged from two to 12. The main limitations were: lack
of blinding of participants, outcome assessors, or care
providers; lack of details about methods of random-
isation and concealment of allocation; failure to report a
sample size calculation, point estimates, andmeasures of
variability; poor follow up; and no intention to treat
analysis.
The main problem with the quality of the
implementation was the lack of information about
Table 1 Methodological quality of included studies with stage based interventions aimed at smoking cessation—continued from previous page
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Berman et al
1995w1
4/13 No No Yes Not stated Yes Yes Not stated Partial Yes Not stated
Butler et al
1999w2
9/13 Yes Yes Yes Yes No Yes Not stated Yes Not stated Yes
Cornuz et al
2002w3
12/13 Yes Yes Yes Yes Yes Yes Not stated Yes Yes Yes
DiClemente et
al 1991w4
5/13 No No Yes No Yes Yes Yes Yes No Yes
Dijkstra et al
1999w5
6/11 No Yes Yes Not stated Yes Yes Not stated Yes Not stated Not
applicable
Emmons et al
2001w6
9/13 No Yes Yes Yes Yes Yes Not stated Yes No Yes
Etter and
Perneger
2001w7
9/13 Yes Yes Yes Yes Yes Yes Yes Yes Yes Not
applicable
Gritz et al
1993w8
3/13 No Yes Yes Not stated No Yes Not stated Partial Yes Yes
Lennox et al
1998w9
8/13 Yes No Yes Yes Yes Yes Yes Health
professionals
Yes Yes
Lennox et al
2001w10
7/13 No Yes Yes Yes Yes Yes Not stated Yes Yes Not
applicable
Morgan et al
1996w11
5/13 No Yes Yes Not stated Yes Not stated Not stated Yes Yes Yes
Pallonen et al
1994w12
2/12 No No Yes No No Yes Not stated Yes Yes Not stated
Pallonen et al
1998w13
6/12 Yes No Yes Not stated Yes Yes Not stated Yes Yes Not
applicable
Pieterse et al
2001w14
8/13 Yes Yes Yes No Yes Yes Not stated Yes Yes Yes
Pletsch
2002w15
6/13 Yes No Yes No Yes Yes Not stated Yes No No
Prochaska et al
2001w16
5/13 No Yes Yes No Yes Yes Not stated Yes No Not
applicable
Prochaska et al
2001w17
5/13 No Yes Yes No Yes Yes Not stated Yes No Not
applicable
Reeve et al
2000w18
3/13 No No Yes No Yes Yes Not stated Yes No No
Resnicow et al
1997w19
7/13 Yes No Yes Yes Yes Yes Not stated Yes Yes Yes
Sinclair et al
1999w20
3/13 No Not stated Not stated Not stated Yes Not stated Not stated Yes Yes Yes
Stotts et al
2002w21
6/13 No No Yes No Yes Yes Not stated Yes Yes Yes
Tappin et al
2000w22 w24
8/13 No Yes Yes No Yes Yes Not stated Yes Yes Yes
Wang 1994w23 6/13 Yes Not stated Yes Not stated Yes Yes Not stated Health
professionals
Not stated Yes
* Maximum score for the 13 items is 11 or 12 if blinding of care providers, participants, or both not applicable. Quality assessment was carried out, using an existing quality assessment tool by
one reviewer and checked by a second, using following predefined criteria: 1. method of intervention allocation reported; 2. intervention allocation concealed; 3. participants blind to existence of
other conditions (scored as “not applicable” if group receiving no intervention at all was included; then blinding considered not possible); 4. outcome assessors blinded to intervention allocation;
5. care providers or educators blind to existence of other conditions (not applicable if intervention did not involve educators); 6. groups similar at baseline (if not similar, 6a. were analyses
adjusted for these differences); 7. last follow up includes 80% or more of randomised participants; 8. eligibility criteria specified; 9. point estimates and measure of variability presented for
primary outcome measure (behaviour change); 10. intention to treat analysis used or differences between drop outs and patients who completed trial explained; 11. statistical methods described;
12. calculation of statistical power or required sample size reported; 13. groups treated identical other than named interventions (scored as “yes” unless clear that contamination of interventions
may have been present); 14. participants’ stage of change assessed before intervention; 15. stages of change instrument validated; 16. interventions tailored to individual stage of change (yes,
partial (for example, only booster sessions stage matched), intervention aimed at health professionals including some data on participants); 17. quality of implementation recorded; 18. details of
training of people giving intervention reported where applicable.
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thevalidity of the instruments used to assess stage of
change. This is important because stage based
interventions depend on accurate assessment of the
stages. It was therefore difficult for us to determine the
extent to which interventions were stage based.
Effectiveness
In eight trials we found statistically significant
differences in cessation rate in favour of the
intervention group (table 2).w3 w4 w7 w11 w12 w14 w16 w23 In seven
of these the comparator was usual carew3 w7 w11 w12 w14 w16 w23
and in one a non-stage based intervention.w4
In 12 trials we found no statistically significant dif-
ferences between groups in smoking behaviour after
the intervention.w1 w5 w6 w8-w10 w13 w15 w18-w20 w22 In five of these
the comparator was usual care,w5 w8 w15 w20 w22 and in eight
a non-stage based intervention.w1 w5 w6 w9 w10 w13 w18 w19
In three studies the findings were inconclusive, for
three reasons.w2 w17 w21 Firstly, when there were multiple
outcomes for smoking behaviour, some were positively
influenced by the intervention (self reported absti-
nence in previous 24 hours, percentage smoking
within five minutes of waking), whereas others were not
(self reported abstinence in previous month, attempts
at quitting, and numbers of cigarettes cut down).w2 Sec-
ondly, when the effectiveness of more than one stage
based intervention was examined and the direction of
the effects of these interventions differed—for example,
two stage based interventions (interactive expert
system and expert system plus counsellor calls) showed
statistically significant effects in comparison with the
no intervention control group, favouring the stage
based interventions, whereas the third stage based
intervention (expert system plus stimulus control com-
puter) showed no statistically significant effects at six
and 12 months and statistically significant effects
favouring the no intervention control group at 18
months.w17 Thirdly, when participants were assessed at
different points of follow up, and the short term follow
up (six weeks) showed statistically significant effects of
the intervention, but at longer term follow up (three
and six months) differences were no longer statistically
significant.w21 In each case, whether multiple outcomes,
multiple interventions, or multiple assessments, there
was no clear evidence on the effectiveness of the inter-
ventions, and we therefore classified them as inconclu-
sive. Only 10 trials reported movement through stages
as an outcome.w2 w3 w5 w9 w12 w13 w15 w18 w21 w22 In five trials this
was in comparison with a non-stage based interven-
tion.w2 w5 w9 w13 w18 One trial showed statistically significant
effects in favour of the stage based intervention.w2 In
another trial, findings were inconclusive,w5 and in three
trials no statistically significant differences between
groups inmovement through stages were found.w9 w13 w18
In six trials this was in comparison with usual
care.w3 w5 w12 w15 w21 w22 In two trials, findings were incon-
clusive.w5 w12 In four trials, no statistically significant
differences between groups in movement through
stages were found.w3 w15 w21 w22
Differences in effectiveness between studies
The trials reporting positive effects for the stage based
interventions were compared in a qualitative way with
the remaining trials on several dimensions that could
have influenced the findings. These included method-
ological quality, number, mean age and sex of
respondents, type of respondents, year of publication,
setting, and type of outcome measures (table 3). Over-
all, larger studies tended to report more positive
outcomes of the stage based interventions than smaller
Table 2 Summary results of included studies with interventions aimed at smoking cessation
Reference
Methodological
quality*
Stage based versus non-stage based Stage based versus no intervention
Mainly
significant†
Mixed
outcomes‡
No significant
difference
Mainly
significant†
Mixed
outcomes‡
No significant
difference
All interventions 1 2 8 7 2 6
Berman et al 1995w1 4/13 — — Yes — — —
Butler et al 1999w2 9/13 — Yes — — — —
Cornuz et al 2002w3 12/13 — — — Yes — —
DiClemente et al 1991w4 5/13 Yes — — — — —
Dijkstra et al 1999w5 6/11 — — Yes — — Yes
Emmons et al 2001w6 9/13 — — Yes — — —
Etter and Perneger 2001w7 9/13 — — — Yes — —
Gritz et al 1993w8 3/13 — — — — — Yes
Lennox et al 1998w9 8/13 — — Yes — — —
Lennox et al 2001w10 7/13 — — Yes — — Yes
Morgan et al 1996w11 5/13 — — — Yes — —
Pallonen et al 1994w12 2/12 — — — Yes — —
Pallonen et al 1998w13 6/12 — — Yes — — —
Pieterse et al 2001w14 8/13 — — — Yes — —
Pletsch 2002w15 6/13 — — — — — Yes
Prochaska et al 2001w16 5/13 — — — Yes — —
Prochaska et al 2001w17 5/13 — — — — Yes —
Reeve et al 2000w18 3/13 — — Yes — — —
Resnicow et al 1997w19 7/13 — — Yes — — —
Sinclair et al 1999w20 3/13 — — — — — Yes
Stotts et al 2002w21 6/13 — — — — Yes —
Tappin et al 2000w22 w24 8/13 — — — — — Yes
Wang 1994w23 6/13 — Yes — Yes — —
*Maximum score for the 13 items is 11 or 12 if blinding of care providers, participants, or both, not applicable.
†Mainly significant outcomes in favour of stage based intervention.
‡Either one stage based intervention showed significant effects and another stage based intervention did not; some behavioural outcomes showed significant effects
in favour of stage based intervention and others did not; or analyses were not conclusive.
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studies. This was also the case for studies that relied on
smoking status being self reported rather than
validated. For studies that compared a stage based
intervention with a non-stage based intervention,more
recent studies were less likely to report positive
outcomes related to stage based interventions. None of
the other factors seemed to differ between studies that
reported positive outcomes of stage based interven-
tions and studies that failed to find positive effects.
Studies that compared a stage based intervention with
usual care, studies of a higher quality, studies that were
set in the community, or studies where the participants
were male, volunteers, or people aged between 30 and
60 years tended to report more positive effects in
favour of stage based interventions. The usefulness of
this information is not clear, however, as these findings
may have resulted from chance, because of the small
number of studies in each group.
Cost effectiveness
Two trials included an economic evaluation.w2 w20 In a
1999 study evaluating the effects of motivational
consulting delivered by general practitioners, the mar-
ginal cost per person who quitted was estimated at
£450.65, which could fall to an extreme of £265.00
with increased use.w2 In another 1999 study, in which
pharmacists provided tailored advice on smoking
cessation, the incremental cost effectiveness ratio for
the intervention was estimated at £300.00 per person
who quitted.w20
Stage assessment
Only two trials evaluating stage based interventions
reported information on the validation of the
instrument used to assess stage of change (Biener’s
contemplation ladder and the University of Rhode
Island change assessment).w4 w9 The level of validation
of the instruments was limited both for internal
reliability and construct validity.
Discussion
Despite the widespread and uncritical use of stage
based interventions in smoking cessation, we found
only limited evidence for their effectiveness.20 21 This
could be due in part to problems with the way in which
stage based interventions have been used or imple-
mented in practice rather than to problems with the
model. Studies with positive outcomes may have
utilised more fully the processes of change within their
design. However, the studies included in our review
provided little evidence to support this assumption.
Table 3 Summary table of issues related to effectiveness of interventions aimed at smoking cessation
Study details No
Stage based versus non-stage based intervention Stage based versus no intervention
Mainly
significant*
Mixed
outcome†
No significant
difference
Mainly
significant*
Mixed
outcome†
No significant
difference
Quality of studies (No of items addressed):
≤4 5 0 0 2 1 0 2
5-8 14 1 1 5 4 2 4
>8 4 0 1 1 2 0 0
No of participants:
≤100 4 0 1 1 1 0 2
101-500 8 0 0 3 2 1 2
501-1000 4 0 1 1 2 0 1
>1000 7 1 0 3 2 1 1
Year of publication:
Before 1996 5 1 1 1 2 0 1
1996-98 4 0 0 3 1 0 0
1999-2000 5 0 1 2 0 0 3
2001 or later 9 0 0 2 4 2 2
Setting:
Community 9 1 0 4 3 1 1
Clinic 13 0 2 3 4 1 5
School 1 0 0 1 0 0 0
Mean age (years):
≤30 5 0 0 2 0 1 2
31-40 7 1 0 2 3 1 0
41-50 5 0 2 2 2 0 1
>50 3 0 0 0 2 0 1
Respondents:
Patients 2 0 0 0 1 0 1
People on low income 4 0 0 3 0 0 1
Students 1 0 0 1 0 0 0
Pregnant women 2 0 0 0 0 1 1
Volunteers 14 1 2 4 6 1 3
Sex:
>60% female 9 1 1 3 1 1 3
>60% male 5 0 1 1 3 0 1
Self report measures:
Only self report 16 1 2 6 5 1 3
Self report with verification 7 0 0 2 2 1 3
*Mainly significant outcomes in favour of stage based intervention.
†Either one stage based intervention showed significant effects and another stage based intervention did not; some behavioural outcomes showed significant effects
in favour of stage based intervention and others did not; or analyses were not conclusive.
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Similarly, participants’ degree of exposure to the inter-
vention did not seem to be related to the effectiveness
of the intervention either.
From a theoretical perspective, the effectiveness of
any stage based intervention depends on accurate
classification of a participant’s particular stage of
change. However, only two of the 23 included trials
used a previously validated instrument, and the level of
validation was limited.
Many of the included studies provided only a
limited description of the content of the intervention,
making it difficult for us to determine if, how, and to
what extent stages of change were used in tailoring the
intervention. In particular, it was unclear whether the
intervention was tailored to a participant’s particular
stage of change.
Finally, the duration of follow up may have been
inadequate to assess changes in movement through
stages or smoking behaviour. Twelve of the studies
lasted between three and nine months, whereas the
action stage was often defined as having quit smoking
within the past six months and the maintenance stage
as having quit smoking more than six months
previously.
Conclusion
Although there is a substantial volume of research
focusing on stages of change, much of it does not
address the effectiveness of the approach in changing
smoking behaviour. Studies that have evaluated effec-
tiveness have often used designs that are not optimal for
establishing evidence of effect. There is a need for well
designed and appropriately implemented randomised
controlled trials that are based on appropriately staged
interventions. These can only be derived from accurate
measurement of the individual’s stage of smoking,
involving frequent reassessment of readiness to change
to provide evolving, stage specific interventions.
We evaluated the effectiveness of interventions
based on one theoretical approach—stage based
approaches to smoking cessation. The evidence
suggests that stage based interventions are no more
effective than non-stage based interventions or no
intervention in changing smoking behaviour. Further
systematic reviews are needed to evaluate the effective-
ness of interventions based on other theoretical
approaches.
Evidence for the effectiveness of the stages of
change approach in changing smoking behaviour is
limited. The methodological quality of the included
randomised controlled trials was mixed and few
reported any validation of the instrument used to
assess participants’ stage of change. There was little
consistency in the types of interventions employed
once participants were classified into stages, and often
the description of the intervention was so limited that it
was unclear whether the intervention was properly
stage based. Methodologically sound and theoretically
consistent intervention studies are required to assess
adequately the efficacy of stage based approaches to
changing smoking behaviour.
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